Concepts (64)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glutathione Peroxidase | 1 | 2022 | 31 | 0.820 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2023 | 105 | 0.810 |
Why?
|
| Integrin beta1 | 1 | 2013 | 54 | 0.430 |
Why?
|
| NF-kappa B | 2 | 2013 | 462 | 0.420 |
Why?
|
| Cell Culture Techniques | 1 | 2013 | 288 | 0.390 |
Why?
|
| Head and Neck Neoplasms | 2 | 2023 | 465 | 0.310 |
Why?
|
| Dinoprostone | 1 | 2022 | 76 | 0.200 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 2478 | 0.180 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 342 | 0.180 |
Why?
|
| Radiation Tolerance | 2 | 2013 | 53 | 0.180 |
Why?
|
| Antineoplastic Agents | 2 | 2023 | 1672 | 0.160 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 535 | 0.160 |
Why?
|
| Cell Line, Tumor | 4 | 2023 | 3297 | 0.140 |
Why?
|
| Cisplatin | 2 | 2023 | 250 | 0.130 |
Why?
|
| Radiation, Ionizing | 1 | 2013 | 41 | 0.110 |
Why?
|
| Mice | 4 | 2022 | 17624 | 0.110 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2023 | 714 | 0.110 |
Why?
|
| Phenylenediamines | 1 | 2013 | 25 | 0.110 |
Why?
|
| Transcription Factor RelA | 1 | 2013 | 53 | 0.110 |
Why?
|
| Tumor Burden | 1 | 2013 | 229 | 0.100 |
Why?
|
| Extracellular Matrix | 1 | 2013 | 232 | 0.100 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 347 | 0.100 |
Why?
|
| Mice, Nude | 1 | 2013 | 697 | 0.100 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2011 | 55 | 0.090 |
Why?
|
| Cell Survival | 1 | 2013 | 817 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2013 | 1105 | 0.090 |
Why?
|
| Binding Sites | 1 | 2013 | 1294 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 879 | 0.090 |
Why?
|
| Cell Line | 2 | 2013 | 2787 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2011 | 187 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 1351 | 0.080 |
Why?
|
| Animals | 4 | 2022 | 33870 | 0.080 |
Why?
|
| Protein Binding | 1 | 2013 | 1736 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2011 | 465 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2011 | 524 | 0.070 |
Why?
|
| Superoxide Dismutase | 1 | 2007 | 138 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 1113 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 1280 | 0.060 |
Why?
|
| Skin | 1 | 2007 | 506 | 0.060 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2023 | 30 | 0.050 |
Why?
|
| Aurora Kinase B | 1 | 2022 | 8 | 0.050 |
Why?
|
| Receptor, Notch1 | 1 | 2022 | 67 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2022 | 492 | 0.040 |
Why?
|
| Glucose | 1 | 2023 | 875 | 0.040 |
Why?
|
| Neoplasms | 1 | 2011 | 2697 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2022 | 2321 | 0.030 |
Why?
|
| Humans | 4 | 2023 | 121793 | 0.030 |
Why?
|
| Protein Inhibitors of Activated STAT | 1 | 2011 | 5 | 0.020 |
Why?
|
| G2 Phase | 1 | 2011 | 45 | 0.020 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2011 | 20 | 0.020 |
Why?
|
| Cell Division | 1 | 2011 | 793 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2011 | 483 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2011 | 347 | 0.020 |
Why?
|
| DNA Damage | 1 | 2011 | 517 | 0.020 |
Why?
|
| DNA Repair | 1 | 2011 | 580 | 0.020 |
Why?
|
| Cyclin B1 | 1 | 2007 | 9 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2007 | 69 | 0.020 |
Why?
|
| Cyclin B | 1 | 2007 | 23 | 0.020 |
Why?
|
| 14-3-3 Proteins | 1 | 2007 | 54 | 0.020 |
Why?
|
| Female | 1 | 2013 | 64573 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 664 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 1881 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2007 | 1616 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2007 | 907 | 0.010 |
Why?
|